Why is Dr Agarwal's Eye falling/rising?

As of 15-Sep, Dr Agarwals Eye Hospital Ltd's stock price is flat at 4,650.00, showing no change (0.00%). The stock has performed in line with its sector today, with moving averages indicating it is higher than the 5-day, 20-day, 50-day, and 100-day averages but lower than the 200-day average. Despite a recent decline in investor participation, with delivery volume falling by 34.24% against the 5-day average, the stock has shown healthy long-term growth, with an annual operating profit growth rate of 61.38%. The company reported its highest quarterly net sales and operating profit margins recently, and while it has generated a return of 13.14% over the past year, its profits have increased by 18.1%, indicating a solid performance relative to its historical valuations. In the broader market context, the stock has outperformed the benchmark Sensex over the past week and month, with returns of 3.22% and 3.31%, respectively, compared to the Sensex's 1.24% and 1.47%. However, year-to-date, the stock has underperformed, showing a decline of 24.11% against the Sensex's gain of 4.67%. This mixed performance suggests that while the stock has strong fundamentals and consistent returns over the last three years, its recent price stability may reflect broader market conditions and investor sentiment, particularly given the decline in trading volume.